Epigenetic regulation of beta-endorphin synthesis in hypothalamic arcuate nucleus neurons modulates neuropathic pain in a rodent pain model.
Yu TaoYuan ZhangXiaohong JinNan HuaHong LiuRenfei QiZitong HuangYufang SunDongsheng JiangTerrance P SnutchXinghong JiangJin TaoPublished in: Nature communications (2023)
Although beta-endorphinergic neurons in the hypothalamic arcuate nucleus (ARC) synthesize beta-endorphin (β-EP) to alleviate nociceptive behaviors, the underlying regulatory mechanisms remain unknown. Here, we elucidated an epigenetic pathway driven by microRNA regulation of β-EP synthesis in ARC neurons to control neuropathic pain. In pain-injured rats miR-203a-3p was the most highly upregulated miRNA in the ARC. A similar increase was identified in the cerebrospinal fluid of trigeminal neuralgia patients. Mechanistically, we found histone deacetylase 9 was downregulated following nerve injury, which decreased deacetylation of histone H3 lysine-18, facilitating the binding of NR4A2 transcription factor to the miR-203a-3p gene promoter, thereby upregulating miR-203a-3p expression. Further, increased miR-203a-3p was found to maintain neuropathic pain by targeting proprotein convertase 1, an endopeptidase necessary for the cleavage of proopiomelanocortin, the precursor of β-EP. The identified mechanism may provide an avenue for the development of new therapeutic targets for neuropathic pain treatment.
Keyphrases
- neuropathic pain
- spinal cord
- transcription factor
- spinal cord injury
- histone deacetylase
- dna binding
- cerebrospinal fluid
- dna methylation
- end stage renal disease
- gene expression
- ejection fraction
- newly diagnosed
- chronic kidney disease
- poor prognosis
- prognostic factors
- genome wide identification
- genome wide
- long non coding rna
- copy number
- binding protein